Inventor
DAHL RUSSELL
US29 patents
⚠️ This page may combine multiple inventors who share the name “DAHL RUSSELL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DAHL RUSSELL
9 patentsUS10772881B2Sep 15, 2020
Quinolines that modulate SERCA and their use for treating disease
DAHL RUSSELL5 citations72
US10383868B2Aug 20, 2019
Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseases
DAHL RUSSELL5 citations72
US11220498B2Jan 11, 2022
Neuroprotective aminothiazoles
DAHL RUSSELL0 citations61
US11213701B2Jan 4, 2022
Neuroprotective quinoline sulfonamides
DAHL RUSSELL0 citations61
US10793558B2Oct 6, 2020
Quinoline oxadiazoles as cytoprotective agents
DAHL RUSSELL0 citations51
US10730839B2Aug 4, 2020
Quinolines as cytoprotective agents
DAHL RUSSELL0 citations51
US10730843B1Aug 4, 2020
Quinoxalines useful as cytoprotective agents
DAHL RUSSELL0 citations51
US10383867B2Aug 20, 2019
Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disorders
DAHL RUSSELL0 citations51
US10800766B2Oct 13, 2020
Quinoline alkenes as cytoprotective agents
DAHL RUSSELL0 citations40
NEURODON CORP
5 patentsUS11890279B2Feb 6, 2024
Quinolines that modulate SERCA and their use for treating disease
NEURODON CORP1 citations71
US11730729B2Aug 22, 2023
Quinolines that modulate SERCA and their use for treating disease
NEURODON CORP1 citations71
US12144806B2Nov 19, 2024
Quinolines that modulate SERCA and their use for treating disease
NEURODON CORP0 citations61
US11992487B2May 28, 2024
Quinolines that modulate SERCA and their use for treating disease
NEURODON CORP0 citations61
US11827626B2Nov 28, 2023
Quinolines that modulate SERCA and their use for treating disease
NEURODON CORP1 citations61
ITHERX PHARMACEUTICALS INC
3 patentsUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE
3 patentsUS10011578B2Jul 3, 2018
Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE0 citations44
US9725429B2Aug 8, 2017
Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE0 citations44
US9102645B2Aug 11, 2015
Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE0 citations44